| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:FAK/aurora kinase-IN-1
CAS:2178117-69-4
Package:1removed
|
|
| | FAK/aurora kinase-IN-1 Basic information |
| Product Name: | FAK/aurora kinase-IN-1 | | Synonyms: | FAK/aurora kinase-IN-1;Benzeneacetamide, 2-[[5-chloro-2-[[6-(4-morpholinyl)-3-pyridinyl]amino]-4-pyrimidinyl]amino]-N,N-dimethyl-α-oxo- | | CAS: | 2178117-69-4 | | MF: | C23H24ClN7O3 | | MW: | 481.94 | | EINECS: | | | Product Categories: | | | Mol File: | 2178117-69-4.mol |  |
| | FAK/aurora kinase-IN-1 Chemical Properties |
| Boiling point | 701.393±70.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.395±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 5.256±0.10(predicted) |
| | FAK/aurora kinase-IN-1 Usage And Synthesis |
| Uses | FAK/Aurora kinase-IN-1 is a FAK and aurora kinase inhibitor with IC50 values of 6.61 nM and 0.91 nM, respectively. FAK/Aurora kinase-IN-1 shows anticancer effects (WO2018019252A1; compound 11)[1]. | | References | [1] Wenlai Zhou, et al. Novel fused pyridine derivatives useful as fak/aurora kinase inhibitors. WO2018019252A1. |
| | FAK/aurora kinase-IN-1 Preparation Products And Raw materials |
|